The Meq oncoprotein of Marek's disease virus interacts with p53 and inhibits its transcriptional and apoptotic activities

Virology Journal

Volumn 7, Issue , 2010, Pages

  Deng, Xufang ^a   Li, Xiangdong ^a   Shen, Yang ^a   Qiu, Yafeng ^a   Shi, Zixue ^a   Shao, Donghua ^a   Jin, Yamei ^a   Chen, Hongjun ^a   Ding, Chan ^a   Li, Li ^b   Chen, Puyan ^c   Ma, Zhiyong ^a  

^a INSTITUTE OF EDIBLE FUNGI   (China)

^b Guangxi Botanical Garden of Medicinal Plants   (China)

^c NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MEQ; PROTEIN P53; UNCLASSIFIED DRUG; VIRUS PROTEIN; LUCIFERASE; ONCOPROTEIN;

APOPTOSIS; ARTICLE; BINDING SITE; DELETION MUTANT; GENETIC TRANSCRIPTION; IMMUNOPRECIPITATION; LYMPHOMA; MALIGNANT TRANSFORMATION; MARDIVIRUS; MAREK DISEASE; NICK END LABELING; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; CHICKEN; DRUG ANTAGONISM; GENE DELETION; GENETICS; HUMAN; METABOLISM; PATHOGENICITY; PROTEIN ANALYSIS; REPORTER GENE; TWO HYBRID SYSTEM;

GALLID HERPESVIRUS 2; GALLUS GALLUS; HERPESVIRIDAE;

ANIMALS; APOPTOSIS; BINDING SITES; CELLS, CULTURED; CHICKENS; GENE DELETION; GENES, REPORTER; HUMANS; IMMUNOPRECIPITATION; IN SITU NICK-END LABELING; LUCIFERASES; MARDIVIRUS; ONCOGENE PROTEINS; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; SEQUENCE DELETION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TWO-HYBRID SYSTEM TECHNIQUES; VIRAL PROTEINS;

EID: 78649322656     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-7-348     Document Type: Article

References (32)

1. T-cell transformation by Marek's disease virus. NL Ross, Trends Microbiol 1999 7 22 29 10.1016/S0966-842X(98)01427-9 10068994
2. Pathogenesis of Marek's disease virus infection. BW Calnek, Curr Top Microbiol Immunol 2001 255 25 55 11217426
3. Marek's disease virus: from miasma to model. N Osterrieder JP Kamil D Schumacher BK Tischer S Trapp, Nat Rev Microbiol 2006 4 283 294 10.1038/nrmicro1382 16541136
4. Marek's disease: an update on oncogenic mechanisms and control. K Venugopal, Res Vet Sci 2000 69 17 23 10.1053/rvsc.2000.0396 10924389
5. Functional interactions between herpesvirus oncoprotein MEQ and cell cycle regulator CDK2. JL Liu Y Ye Z Qian Y Qian DJ Templeton LF Lee HJ Kung, J Virol 1999 73 4208 4219 10196317
6. Transformation of primary chick embryo fibroblasts by Marek's disease virus. C Buranathai J Rodríguez C Grose, Virology 1997 239 20 35 10.1006/viro.1997.8854 9426443
7. Transforming potential of the herpesvirus oncoprotein MEQ: morphological transformation, serum-independent growth, and inhibition of apoptosis. JL Liu Y Ye LF Lee HJ Kung, J Virol 1998 72 388 395 9420237
8. Marek's disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses. AM Levy O Gilad L Xia Y Izumiya J Choi A Tsalenko Z Yakhini R Witter L Lee CJ Cardona HJ Kung, Proc Natl Acad Sci USA 2005 102 14831 14836 10.1073/pnas.0506849102 16203997
9. Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication. B Lupiani LF Lee X Cui I Gimeno A Anderson RW Morgan RF Silva RL Witter HJ Kung SM Reddy, Proc Natl Acad Sci USA 2004 101 11815 11820 10.1073/pnas.0404508101 15289599 (Pubitemid 39095377)
10. Marek's disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. D Jones L Lee JL Liu HJ Kung JK Tillotson, Proc Natl Acad Sci USA 1992 89 4042 4046 10.1073/pnas.89.9.4042 1315048
11. Nuclear localization and dynamic properties of the Marek's disease virus oncogene products Meq and Meq/vIL8. JM Anobile V Arumugaswami D Downs K Czymmek M Parcells CJ Schmidt, J Virol 2006 80 1160 1166 10.1128/JVI.80.3.1160-1166.2006 16414993
12. In The 5th International Symposium on Marek's disease. P Brunovskis Z Qian D Li, Kellogg Center, Michigan State University, East Lansing, Michigan: AAAP, Kennett Square, Pennsylvania 1996 265 270
13. Interaction of MEQ protein and C-terminal-binding protein is critical for induction of lymphomas by Marek's disease virus. AC Brown SJ Baigent LP Smith JP Chattoo LJ Petherbridge P Hawes MJ Allday V Nair, Proc Natl Acad Sci USA 2006 103 1687 1692 10.1073/pnas.0507595103 16446447
14. Interaction of Marek's disease virus oncoprotein Meq with heat shock protein 70 in lymphoid tumour cells. Y Zhao D Kurian H Xu L Petherbridge LP Smith L Hunt V Nair, J Gen Virol 2009 90 2201 2208 10.1099/vir.0.012062-0 19494050
15. p53, the cellular gatekeeper for growth and division. AJ Levine, Cell 1997 88 323 331 10.1016/S0092-8674(00)81871-1 9039259
16. Human tumor suppressor p53 and DNA viruses. S Collot-Teixeira J Bass F Denis S Ranger-Rogez, Rev Med Virol 2004 14 301 319 10.1002/rmv.431 15334538
17. Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. PR Yew AJ Berk, Nature 1992 357 82 85 10.1038/357082a0 1533443
18. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. LW Elmore AR Hancock SF Chang XW Wang S Chang CP Callahan DA Geller H Will CC Harris, Proc Natl Acad Sci USA 1997 94 14707 14712 10.1073/pnas.94.26.14707 9405677
19. New insights into the mechanism of inhibition of p53 by simian virus 40 large T antigen. HM Sheppard SI Corneillie C Espiritu A Gatti X Liu, Mol Cell Biol 1999 19 2746 2753 10082540
20. Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription. Y Sato N Shirata A Kudoh S Iwahori S Nakayama T Murata H Isomura Y Nishiyama T Tsurumi, Virology 2009 388 204 211 10.1016/j.virol.2009.03.017 19375142
21. Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities. F Yi A Saha M Murakami P Kumar JS Knight Q Cai T Choudhuri ES Robertson, Virology 2009 388 236 247 10.1016/j.virol.2009.03.027 19394062
22. Novel criteria for the diagnosis of Marek's disease virus-induced lymphomas. IM Gimeno RL Witter AM Fadly RF Silva, Avian Pathol 2005 34 332 340 10.1080/03079450500179715 16147570
23. Nucleolar and nuclear localization properties of a herpesvirus bZIP oncoprotein, MEQ. JL Liu LF Lee Y Ye Z Qian HJ Kung, J Virol 1997 71 3188 3196 9060682
24. Alterations in p53 and E2F-1 function common to immortalized chicken embryo fibroblasts. H Kim S You IJ Kim LK Foster J Farris S Ambady FA Ponce de Leán DN Foster, Oncogene 2001 20 2671 2682 10.1038/sj.onc.1204378 11420679
25. Constitutive expression of the cyclin-dependent kinase inhibitor p21 is transcriptionally regulated by the tumor suppressor protein p53. HY Tang K Zhao JF Pizzolato M Fonarev JC Langer JJ Manfredi, J Biol Chem 1998 273 29156 29163 10.1074/jbc.273.44.29156 9786925
26. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. T Juven Y Barak A Zauberman DL George M Oren, Oncogene 1993 8 3411 3416 8247544
27. Suppression of transcription activity of the MEQ protein of oncogenic Marek's disease virus serotype 1 (MDV1) by L-MEQ of non-oncogenic MDV1. KS Chang K Ohashi M Onuma, J Vet Med Sci 2002 64 1091 1095 10.1292/jvms.64.1091 12520099
28. Diversity (polymorphism) of the meq gene in the attenuated Marek's disease virus (MDV) serotype 1 and MDV-transformed cell lines. KS Chang K Ohashi M Onuma, J Vet Med Sci 2002 64 1097 1101 10.1292/jvms.64.1097 12520100
29. Identification and characterization of a novel spliced form of the meq transcript in lymphoblastoid cell lines derived from Marek's disease tumours. T Okada M Takagi S Murata M Onuma K Ohashi, J Gen Virol 2007 88 2111 2120 10.1099/vir.0.82744-0 17622612
30. Splicing together different regions of a gene by modified polymerase chain reaction-based site-directed mutagenesis. X Li Y Qiu Y Shen C Ding P Liu J Zhou Z Ma, Anal Biochem 2008 373 398 400 10.1016/j.ab.2007.10.021 18022376
31. Nucleotide sequence of a cDNA encoding the chicken p53 nuclear oncoprotein. T Soussi A Bègue M Kress D Stehelin P May, Nucleic Acids Res 1988 16 11383 10.1093/nar/16.23.11383 3060861 (Pubitemid 19008484)
32. Polyclonal antibody to porcine p53 protein: a new tool for studying the p53 pathway in a porcine model. Y Qiu Y Shen X Li Q Liu Z Ma, Biochem Biophys Res Commun 2008 377 151 155 10.1016/j.bbrc.2008.09.117 18840405